Holman RR - Search Results

1

Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial.

Price HC, Griffin SJ, Holman RR. Price HC, et al. Among authors: holman rr. Diabet Med. 2011 Mar;28(3):363-72. doi: 10.1111/j.1464-5491.2010.03212.x. Diabet Med. 2011. PMID: 21309847 Clinical Trial.

2

Modelling incremental benefits on complications rates when targeting lower HbA_1c levels in people with Type 2 diabetes and cardiovascular disease.

Mostafa SA, Coleman RL, Agbaje OF, Gray AM, Holman RR, Bethel MA. Mostafa SA, et al. Among authors: holman rr. Diabet Med. 2018 Jan;35(1):72-77. doi: 10.1111/dme.13533. Epub 2017 Nov 16. Diabet Med. 2018. PMID: 29057545

3

Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?

Paul SK, Holman RR. Paul SK, et al. Among authors: holman rr. Diabet Med. 2017 Sep;34(9):1284-1290. doi: 10.1111/dme.13376. Epub 2017 Jun 13. Diabet Med. 2017. PMID: 28477414 Clinical Trial.

4

Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study.

Preiss D, Rankin N, Welsh P, Holman RR, Kangas AJ, Soininen P, Würtz P, Ala-Korpela M, Sattar N. Preiss D, et al. Among authors: holman rr. Diabet Med. 2016 Nov;33(11):1569-1574. doi: 10.1111/dme.13097. Epub 2016 Mar 3. Diabet Med. 2016. PMID: 26887663 Clinical Trial.

5

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).

Alva ML, Gray A, Mihaylova B, Leal J, Holman RR. Alva ML, et al. Among authors: holman rr. Diabet Med. 2015 Apr;32(4):459-66. doi: 10.1111/dme.12647. Epub 2015 Jan 7. Diabet Med. 2015. PMID: 25439048

6

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).

Davis TM, Coleman RL, Holman RR; UKPDS Group. Davis TM, et al. Among authors: holman rr. Diabet Med. 2014 Feb;31(2):200-7. doi: 10.1111/dme.12353. Epub 2013 Nov 22. Diabet Med. 2014. PMID: 24267048

7

Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study.

Jenkins N, Hallowell N, Farmer AJ, Holman RR, Lawton J. Jenkins N, et al. Among authors: holman rr. Diabet Med. 2011 May;28(5):543-8. doi: 10.1111/j.1464-5491.2010.03200.x. Diabet Med. 2011. PMID: 21480965 Free article.

8

Framingham risk equations underestimate coronary heart disease risk in diabetes.

Stevens RJ, Coleman RL, Holman RR. Stevens RJ, et al. Among authors: holman rr. Diabet Med. 2005 Feb;22(2):228. doi: 10.1111/j.1464-5491.2005.01387.x. Diabet Med. 2005. PMID: 15660747 No abstract available.

9

Poor pregnancy outcome for women with Type 2 diabetes.

Hadden DR, Cull CA, Croft DJ, Holman RR. Hadden DR, et al. Among authors: holman rr. Diabet Med. 2003 Jun;20(6):506-7. doi: 10.1046/j.1464-5491.2003.00955_2.x. Diabet Med. 2003. PMID: 12786690 No abstract available.

10

Glycosylated haemoglobin measurement on blood samples taken by patients: an additional aid to assessing diabetic control.

Holman RR, Jelfs R, Causier PM, Moore JC, Turner RC. Holman RR, et al. Diabet Med. 1987 Jan-Feb;4(1):71-3. doi: 10.1111/j.1464-5491.1987.tb00834.x. Diabet Med. 1987. PMID: 2951227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results